We found that large tumor size, high tumor grade, and high tumor stage were significant histopathological predictors of ETR, and that high AFP, the presence of the p53 mutation, and the absence of the β-catenin mutation were significant molecular factors for ETR. The gene discussed is TP53; the disease is neoplasm.